The results indicated that no significant associations were found between serum PLA2G2A levels and clinical factors including age and gender distribution (P > 0.05), whereas higher serum PLA2G2A levels were associated with less frequent lymph node metastasis and lower TNM stages (Table 2). Here, PLA2G2A is linked to metastatic malignant neoplasm in the lymph nodes.